Cutis laxa senilis

L12_CUTLAXSEN

photosensitivity disease: Photosensitivity refers to various symptoms, diseases and conditions caused or aggravated by exposure to sunlight.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L57.4 Hospital discharge: ICD-9 — 7018B Cause of death: ICD-10 — L57.4 Cause of death: ICD-9 — 7018B 2 out of 7 registries used, show all original rules.	264
4. Check minimum number of events None	264
5. Include endpoints None	264
6. Filter based on genotype QC (FinnGen only)	264

Control definitions (FinnGen only)

Control exclude: L12_RADIATIONRELATEDSKIN

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L57
Name in latin: Cutis laxa senilis

NAME	L12_CUTLAXSEN
CONTROL_EXCLUDE	L12_RADIATIONRELATEDSKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L574
HD_ICD_9	7018B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L574
COD_ICD_9	7018B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cutis laxa senilis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1483	1319	155
Only index persons	1385	1244	141
Unadjusted period prevalence (%)
Whole population	0.03	0.04	0.00
Only index persons	0.04	0.05	0.01
Median age at first event (years)
Whole population	55.73	54.96	62.05
Only index persons	55.47	54.72	62.05

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	264	241	23
Unadjusted period prevalence (%)	0.08	0.08	0.01
Median age at first event (years)	55.58	54.76	64.17

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
233: Matched controls
2330

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L57.4

ICD-10 Finland

Cutis laxa senilis

+∞

294.8

216

QAJ30

NOMESCO Finland

Other facelift

+∞

76.3

QBJ30

NOMESCO Finland

Correction of abdominal apron

109.5

54.9

7018B

ICD-9 Finland

Other hypertrophic and atrophic conditions of skin, Other specified hypertrophic and atrophic conditions of skin[ELASTOSIS SENILIS]

+∞

17.9

9862

FHL

Facial skin shaping surgery (Faclift)

103.0

17.8

QBJ00

NOMESCO Finland

Liposuction in trunk

34.3

15.1

L57.0

ICD-10 Finland

Actinic keratosis

7.4

11.9

H02.3

ICD-10 Finland

Blepharochalasis

4.5

11.9

115

J01DB01

ATC

cefalexin; oral

3.6

10.5

209

1647

E66.8

ICD-10 Finland

Other obesity

6.7

10.3

QAJ99

NOMESCO Finland

Other aesthetic operations on skin of head or neck

104.1

9.5

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.3

8.7

131

835

Z41.1

ICD-10 Finland

Other plastic surgery for unacceptable cosmetic appearance

21.0

8.6

N06AB04

ATC

citalopram; systemic

2.6

8.3

339

A02BC05

ATC

esomeprazole; systemic

2.2

7.8

123

783

QAJ15

NOMESCO Finland

Browlift using video-endoscope

82.6

7.5

Z42.2

ICD-10 Finland

Follow-up care involving plastic surgery of other parts of trunk

+∞

7.3

J01EA01

ATC

trimethoprim; systemic

2.2

7.1

526

M62.0

ICD-10 Finland

Diastasis of muscle

71.7

6.5

J02AC01

ATC

fluconazole; systemic

2.0

6.3

126

861

QAJ05

NOMESCO Finland

Other correction of loose or redundant skin of head or neck

+∞

6.3

J01DA01

ATC

[U] cefalexin; systemic

2.0

6.2

160

1206

N05CF01

ATC

zopiclone; oral

2.1

6.2

573

E66.01

ICD-10 Finland

Obesity due to excess calories

3.6

6.1

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

111

721

1.93

6.19

2.1

1.9

120.6

146.3

u/l

0.82

106

677

(3037467) Urinalysis macro (dipstick) panel - Urine

198

1577

2.02

5.77

5.5

4.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

148

1076

1.85

5.66

3.6

4.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

3.35

5.44

1.2

1.1

—

10.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

109

737

1.82

5.14

2.4

2.2

53.6

55.6

u/l

0.39

103

678

(3013707) Erythrocyte sedimentation rate by Westergren method

211

1747

2.04

5.12

4.8

4.1

11.7

12.7

mm/h

0.50

202

1580

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

182

1447

1.83

4.86

3.4

3.0

35.0

45.2

u/l

2.26

170

1343

(36660697) Celiac disease serology panel - Serum

180

2.30

4.83

1.3

1.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

145

1080

1.76

4.83

5.2

5.0

1.2

mmol/l

1.21

132

967

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

153

1174

1.72

4.44

6.2

5.8

1.2

mmol/l

0.76

137

990

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

134

994

1.71

4.38

2.3

2.0

90.8

98.6

pmol/l

1.03

469

(3048689) Calprotectin [Mass/mass] in Stool

288

1.96

4.12

1.7

1.8

91.5

124.0

ug/g

0.65

224

(3013826) Glucose [Moles/volume] in Serum or Plasma

168

1341

1.70

4.05

4.4

4.0

6.2

6.6

mmol/l

2.19

158

1243

(40768804) Tissue Pathology biopsy report

125

927

1.66

3.97

2.4

2.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

211

1800

1.86

3.97

7.6

7.0

72.7

77.7

u/l

1.41

202

1663

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

384

1.80

3.76

3.0

2.6

0.9

1.3

e6/l

0.64

202

(42870588) Differential panel, method unspecified - Blood

102

726

1.66

3.75

5.6

5.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

214

1855

1.81

3.54

4.7

4.3

14.7

14.8

pmol/l

0.28

201

1675

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

249

1.92

3.52

2.3

2.2

5.7

7.0

umol/l

0.41

216

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

241

2175

2.24

3.50

5.9

5.2

1.8

1.9

mu/l

0.24

230

1973

(3026008) Bacteria identified in Urine by Culture

110

811

1.61

3.46

3.1

3.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

353

1.78

3.44

3.1

2.8

3.6

3.8

e6/l

0.06

173

(3012095) Magnesium [Moles/volume] in Serum or Plasma

338

1.79

3.40

3.3

2.7

0.8

mmol/l

0.13

310

(3036481) Cortisol [Moles/volume] in Serum or Plasma

209

1.96

3.30

2.1

1.7

358.6

374.3

nmol/l

0.17

186

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

162

1320

1.59

3.26

3.4

2.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

138

2.15

3.25

2.0

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

361

1.74

3.17

1.9

—

(3033658) Prothrombin time (PT) actual/Normal

582

1.62

3.15

3.3

3.2

94.2

94.1

0.01

566

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

530

1.64

3.15

1.3

7.4

1.2

u/ml

0.45

137

(3032057) Clostridioides difficile [Presence] in Stool

10.16

2.99

1.4

2.4

—

(40761536) Microorganisms panel - Urine sediment

188

0.30

2.95

3.7

3.4

—

(3006653) Thiamine [Moles/volume] in Blood

6.79

2.88

1.2

1.7

115.2

118.1

nmol/l

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

153

1253

1.53

2.84

5.4

5.6

9.8

10.0

umol/l

0.26

148

1181

(3018418) pH of Serum or Plasma

747

1.52

2.67

3.1

3.5

7.4

—

137

(3001122) Ferritin [Mass/volume] in Serum or Plasma

125

993

1.49

2.62

2.7

142.1

98.6

ug/l

0.42

119

895

(3042936) Bacteria identified in Isolate by Culture

314

1.69

2.60

2.0

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

290

1.71

2.59

5.1

4.7

36.1

33.2

0.81

178

(3021960) Folate [Moles/volume] in Serum or Plasma

569

1.53

2.43

1.6

1.5

30.8

22.6

nmol/l

0.73

470

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

133

1.97

2.41

1.8

—

(3019198) Lymphocytes [#/volume] in Blood

138

1131

1.46

2.40

6.2

5.3

1.8

2.0

e9/l

0.93

126

1002

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

249

1.71

2.36

1.8

2.0

—

(3049717) Cytology report of Urine Cyto stain

2.39

2.36

2.1

2.8

—

(3022313) Gas panel - Capillary blood

2.20

2.35

3.6

3.7

—

(1761868) Lipid panel - Serum or Plasma

763

0.63

2.34

3.6

3.0

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

125

1012

1.45

2.29

4.7

3.6

35.3

35.4

g/l

0.09

118

939

(3052851) Hemolysis interference index of Serum or Plasma

2.31

2.22

2.1

3.0

—

(3013115) Eosinophils [#/volume] in Blood

139

1157

1.43

2.14

6.0

5.5

0.2

e9/l

0.50

128

1016

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

248

1.67

2.14

1.8

1.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

127

1041

1.42

2.13

2.4

2.2

83.5

79.5

nmol/l

0.75

114

901

(40768797) Stomach Pathology biopsy report

348

1.58

2.12

1.3

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

178

1.77

2.10

3.8

5.7

1.2

1.3

mmol/l

0.15

167

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2.39

2.08

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

732

1.44

2.07

1.8

2.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

3.14

2.03

2.0

3.1

13.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

553

1.47

2.02

1.9

2.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

165

1.78

2.00

1.1

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

528

1.47

1.98

4.3

3.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

278

1.61

1.98

11.9

6.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

166

1.77

1.97

2.4

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

183

1.72

1.92

1.9

2.6

70.1

75.7

ng/l

0.24

158

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

435

1.49

1.89

4.2

3.7

16.5

191.8

ng/l

2.53

342

(3020564) Creatinine [Moles/volume] in Serum or Plasma

252

2394

2.16

1.89

19.4

16.3

70.0

71.5

umol/l

0.68

252

2394

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

242

2270

1.79

1.88

17.1

13.8

22.0

21.5

mg/l

0.08

196

1773

(3009542) Hematocrit [Volume Fraction] of Blood

220

2017

1.54

1.88

17.8

15.1

38.9

39.4

0.45

158

1433

(3025468) Yersinia sp identified in Specimen by Organism specific culture

2.91

1.87

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

2.91

1.87

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

2.91

1.87

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

2.91

1.87

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

2.91

1.87

1.5

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

527

1.45

1.82

1.5

1.7

0.8

1.0

mg/l

0.95

424

(3001604) Monocytes [#/volume] in Blood

132

1110

1.38

1.82

6.1

5.2

0.5

0.6

e9/l

1.48

122

960

(3019150) Specific gravity of Urine by Refractometry

501

1.45

1.81

4.2

1.0

kg/l

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

2.81

1.80

1.5

1.4

—

(3000991) Gas panel - Venous blood

155

1.75

1.80

3.7

6.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

132

1.81

1.80

2.4

2.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

128

1072

1.38

1.80

6.3

5.5

28.0

28.3

0.10

122

987

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

694

1.40

1.77

2.6

2.7

1030.7

1122.7

ng/l

0.11

587

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2.19

1.74

2.2

1.2

—

(36304419) Bacteria [Presence] in Urine

616

1.40

1.69

3.3

2.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

108

888

1.37

1.67

3.1

3.6

15.4

38.1

ng/l

2.20

620

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

2.85

1.66

1.4

1.7

—

(3019230) Fractional oxyhemoglobin in Venous blood

2.85

1.66

1.1

1.8

43.6

59.4

—

(3019225) pH of Specimen

233

1.58

1.62

3.9

4.1

—

(3021788) Differential panel - Synovial fluid

2.38

1.62

1.6

1.8

—

(3032080) INR in Blood by Coagulation assay

111

922

1.35

1.60

8.7

7.6

1.1

1.2

inr

0.11

275

(3006315) Basophils [#/volume] in Blood

131

1116

1.35

1.59

6.2

5.2

0.0

e9/l

0.25

121

966

(4010399)

170

1.66

1.56

1.5

1.4

—

(40761511) CBC panel - Blood by Automated count

247

2349

1.80

1.56

15.6

13.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

560

1.39

1.55

2.3

2.1

2.8

3.4

mg/l

1.65

468

(3030467) Casts [#/volume] in Urine by Automated count

634

1.38

1.54

3.4

3.0

0.1

0.6

e6/l

3.94

465

(3023368) Bacteria identified in Blood by Culture

570

1.39

1.54

4.2

3.8

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

803

1.35

1.53

3.6

3.0

—

(40758558) Short blood count panel - Blood

599

1.38

1.51

8.1

6.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

221

1.56

1.50

2.3

2.4

40.4

28.6

u/l

0.49

181

(3018095) Leukocytes [#/volume] in Urine

805

1.35

1.50

4.2

3.6

64.9

81.5

e6/l

0.21

558

(3026493) Urate [Moles/volume] in Serum or Plasma

556

1.38

1.47

2.0

2.5

333.1

8763.0

umol/l

3.65

467

(3003327) Ova and parasites identified in Stool by Light microscopy

1.97

1.47

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

2.54

1.46

1.4

1.7

—

(3045414) Leukocytes [Presence] in Urine

103

1.80

1.45

2.0

2.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.77

1.44

1.7

2.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.77

1.44

2.3

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

238

2250

1.59

1.43

5.0

4.7

5.8

5.9

mmol/l

0.94

222

2030

(3019069) Monocytes/100 leukocytes in Blood

123

1052

1.32

1.41

6.7

5.6

8.4

8.3

0.17

117

978

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2.12

1.40

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2.12

1.40

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

681

1.34

1.39

2.8

2.9

6.4

6.6

mmol/l

0.22

557

(40761535) Cells panel - Urine sediment

184

1.58

1.39

3.3

3.4

—

(3024928) Oxygen saturation in Venous blood

2.24

1.38

1.2

1.7

—

(44790047)

2.64

1.37

1.5

1.7

—

(44790048)

2.64

1.37

1.5

1.7

—

(44790049)

2.64

1.37

1.5

1.7

—

(44806118)

2.64

1.37

1.5

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.81

1.32

2.3

1.8

—

(3022096) Basophils/100 leukocytes in Blood

118

1011

1.30

1.31

6.5

5.3

0.7

0.09

112

930

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2.13

1.29

1.0

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

2.81

1.29

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

2.81

1.29

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

2.81

1.29

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

221

1.51

1.29

3.7

5.0

227.7

244.4

u/l

0.55

206

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.32

1.28

1.4

1.6

—

(3012516) Albumin [Mass/volume] in Urine

661

1.33

1.27

2.9

3.0

18.5

145.4

mg/l

0.62

382

(3002582) Erythrocytes [#/volume] in Urine

690

1.32

1.26

3.5

3.1

19.9

32.3

e6/l

1.00

518

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.81

1.26

1.5

1.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

2.26

1.25

1.1

1.4

—

(3006504) Eosinophils/100 leukocytes in Blood

121

1045

1.29

1.25

6.4

5.3

3.0

2.8

0.63

115

965

(3013650) Neutrophils [#/volume] in Blood by Automated count

148

1312

1.29

1.25

8.5

9.0

3.7

4.0

e9/l

1.35

142

1159

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

2.66

1.22

1.0

1.1

—

(3017732) Neutrophils [#/volume] in Blood

149

1.60

1.22

2.9

3.1

3.2

4.0

e9/l

1.08

113

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.79

1.21

2.1

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

464

1.35

1.18

1.7

1.6

2.0

2.3

g/l

0.82

270

(3018010) Neutrophils/100 leukocytes in Blood

122

1062

1.28

1.16

6.3

5.2

56.6

57.2

0.20

117

987

(3021901) Oxygen saturation in Capillary blood

0.00

1.16

0.0

2.6

—

(40768443) Skin Pathology biopsy report

103

1.70

1.16

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

2.53

1.15

2.2

2.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

698

1.30

1.15

3.4

3.8

5.0

7.2

mg/mmol

0.36

403

(3000492) Spirometry study

193

1.50

1.15

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

736

1.29

1.15

3.4

2.8

32.2

31.6

u/l

0.05

705

(46235355) HIV 1 and 2 tests - Meaningful Use set

288

1.42

1.14

1.4

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2.37

1.13

1.1

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

2.37

1.13

1.1

1.3

—

(3044889) 12 lead EKG panel

179

1638

1.29

1.12

3.9

3.8

—

(3009343) pH of Capillary blood

120

1.63

1.12

3.5

—

7.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

251

2424

1.72

1.10

11.9

10.4

25.2

24.0

u/l

0.36

246

2327

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

2.41

1.09

1.2

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

2.22

1.09

1.0

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1.77

1.04

1.3

249.9

272.3

ug/g

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.87

1.04

1.1

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.87

1.04

1.4

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

1.87

1.04

2.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

446

1.32

1.04

1.3

33.0

37.4

iu/ml

0.09

153

(3044941) Cell count panel - Synovial fluid

2.09

1.03

1.7

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

123

1.59

1.03

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1.92

1.02

1.0

1.1

3.5

3.8

mmol/l

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

107

1.63

1.02

4.6

7.7

24.6

25.4

mmol/l

0.67

(3000494) Fungus identified in Specimen by Culture

268

1.40

1.01

2.0

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

2.03

1.00

1.0

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.97

0.0

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.97

0.0

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.97

0.0

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.97

0.0

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.95

0.0

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1.92

0.94

1.6

1.2

53.5

19.0

u/l

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.25

0.94

1.0

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

624

0.77

0.88

2.9

3.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2.02

0.87

1.0

1.2

—

(3019060) Gas panel - Arterial blood

137

1.50

0.87

8.3

4.4

—

(3012544) pH of Venous blood

206

1.40

0.85

1.9

2.8

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

105

1.56

0.84

1.8

2.3

1.1

1.2

0.02

105

(3037522) Nuclear Ab [Titer] in Serum

305

1.33

0.83

1.2

1.4

380.0

594.8

titre

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.89

0.82

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.72

0.81

1.6

—

(1002224) Polysomnography panel

1.59

0.80

1.1

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.79

0.0

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.79

0.0

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.78

0.0

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

0.00

0.78

0.0

8.7

—

6.3

—

(40768795) Lymph node Pathology biopsy report

0.00

0.76

0.0

1.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.82

0.73

5.4

3.9

—

192.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

233

2245

1.32

0.73

4.8

4.6

4.8

mmol/l

0.04

213

2062

(3020891) Body temperature

1.61

0.73

3.6

4.9

—

(3023520) Reticulocytes [#/volume] in Blood

178

1.38

0.72

2.2

3.2

63.2

73.6

e9/l

0.86

137

(3023410) Appearance of Cerebral spinal fluid

1.94

0.71

1.4

1.2

—

(4094501)

1.66

0.69

1.0

—

(3025130) Human papilloma virus identified in Specimen

1.87

0.69

1.4

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

472

1.24

0.68

2.2

2.4

6.6

e6/l

0.01

423

(3021589) Normoblasts [#/volume] in Blood

985

0.84

0.65

7.3

8.8

0.0

e9/l

1.22

808

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.74

0.64

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

232

0.71

0.63

2.1

3.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

224

2157

1.25

0.63

6.7

5.8

38.8

39.6

mmol/mol

0.83

210

1995

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.48

0.63

1.9

2.6

24.4

25.3

mmol/l

0.80

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

231

2233

1.28

0.62

4.9

4.5

1.6

mmol/l

1.14

215

2034

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.62

0.62

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.68

0.61

1.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.60

0.0

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.55

0.60

1.6

1.5

—

(3009261) Glucose [Presence] in Urine by Test strip

126

1158

1.17

0.59

3.8

0.0

estimate

—

202

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.53

0.59

1.6

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.73

0.58

1.3

1.5

—

(3026782) Osmolality of Urine

443

1.22

0.58

2.5

2.6

545.8

521.9

mosm/kgh2o

0.31

380

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

378

1.23

0.57

1.6

1.4

—

(3003694) ABO and Rh group [Type] in Blood

558

1.19

0.56

1.3

1.4

—

(3045424) Erythrocytes [Presence] in Urine

1.59

0.54

1.5

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.59

0.54

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1.49

0.54

1.1

1.2

401.1

480.7

mg/l

—

(3035350) Ketones [Presence] in Urine by Test strip

123

1135

1.16

0.54

3.8

0.0

estimate

—

209

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.54

0.53

1.1

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

495

1.19

0.52

1.5

1.7

513.8

466.2

pmol/l

0.48

398

(3021601) Nitrite [Presence] in Urine by Test strip

124

1147

1.15

0.52

5.0

5.1

0.0

estimate

—

206

(40760892) CBC W Ordered Manual Differential panel - Blood

504

0.82

0.52

5.3

4.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

179

0.71

0.52

2.1

1.7

—

(3022145) Colonoscopy Study observation

262

1.25

0.51

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.45

0.50

1.9

1.2

—

(3002256) Pathology report gross observation

282

1.24

0.49

1.2

—

(3013512) EKG study

691

1.16

0.48

4.1

3.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

111

1.37

0.48

1.9

2.9

24.9

25.3

mmol/l

0.14

111

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.45

0.46

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

1.41

0.45

1.3

5.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.41

0.45

1.9

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

235

2292

1.23

0.44

5.5

5.2

2.7

2.8

mmol/l

0.62

217

2082

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

127

0.70

0.44

2.3

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

240

1.23

0.43

1.8

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.44

0.43

1.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1.57

0.42

1.0

1.4

—

(3000330) Specific gravity of Urine by Test strip

123

1.32

0.41

3.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

0.41

0.0

1.1

—

298.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.41

0.0

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.41

0.0

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

3.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.38

0.40

1.9

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1.34

0.40

1.3

4.8

—

4.2

—

(3025941) Bacteria identified in Stool by Culture

142

1.29

0.39

1.7

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

124

1.31

0.39

1.8

1.4

—

(40768441) Liver Pathology biopsy report

0.00

0.39

0.0

1.1

—

(3022621) pH of Urine by Test strip

170

1.26

0.38

2.8

3.0

—

(3004616) Nuclear Ab [Presence] in Serum

1.40

0.38

1.4

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

152

1.27

0.38

1.9

2.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

220

2141

1.17

0.38

4.3

4.0

1.3

mmol/l

0.00

198

1937

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

126

1.29

0.36

6.3

4.2

15.5

23.6

—

(3016879) Cocaine [Presence] in Urine

1.44

0.36

1.3

1.4

—

(3015736) pH of Urine

883

1.12

0.35

3.9

3.7

—

(3025159) Blasts/100 leukocytes in Blood

166

0.77

0.34

4.2

4.1

0.0

2.2

—

(3028300) Cannabinoids [Presence] in Urine

1.34

0.34

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

1.34

0.34

1.3

—

(3027008) Opiates [Presence] in Urine

1.34

0.34

1.3

—

(3027944) Amphetamines [Presence] in Urine

1.31

0.33

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

153

0.77

0.31

1.7

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.70

0.31

1.4

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1.30

0.28

1.4

4.7

19.6

25.0

mg/l

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1.30

0.28

1.4

4.7

469.4

48.0

mg/l

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1.28

0.28

1.9

2.0

12.9

10.5

mg/l

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

864

1.10

0.28

3.0

2.3

2.4

mmol/l

0.66

738

(3021879) Hepatitis B virus core Ab [Presence] in Serum

131

1.24

0.28

1.3

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.22

0.27

1.3

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

104

1.26

0.27

13.6

7.6

—

(3017181) Myelocytes/100 leukocytes in Blood

181

0.82

0.26

4.2

4.1

0.1

0.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

159

0.81

0.25

4.2

0.0

0.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.32

0.23

2.2

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

219

1.16

0.23

1.3

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

296

1.13

0.22

2.5

2.0

21.6

21.4

0.02

251

(3021440) Promyelocytes/100 leukocytes in Blood

167

0.83

0.22

4.1

4.2

0.0

0.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

163

1.18

0.22

6.2

4.6

1.4

1.9

ug/l

0.44

137

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

15.2

—

860.3

—

(3014271) Vancomycin [Susceptibility]

0.00

0.21

0.0

2.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

0.00

0.21

0.0

1.0

—

77.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.21

0.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

9.6

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.21

0.0

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.21

0.0

3.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.21

0.0

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.21

0.0

1.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

95.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.21

0.0

3.4

—

(3004451) EKG impression Narrative

0.00

0.21

0.0

1.5

—

(3037756) Immunofixation for Serum or Plasma

1.26

0.20

1.5

2.2

—

(3029937) Albumin [Presence] in Urine by Test strip

610

0.92

0.20

4.7

4.0

0.0

estimate

—

205

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.20

0.0

1.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

212

2155

0.92

0.18

14.0

13.2

77.6

78.5

ml/min/173m2

0.26

180

1752

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.15

0.17

2.3

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.74

0.15

1.0

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1.14

0.15

4.2

1.6

1.3

1.6

ug/l

—

(40768793) Breast Pathology biopsy report

1.19

0.14

1.2

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

112

1.17

0.14

1.5

1.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

179

1.13

0.14

1.5

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

463

1.07

0.13

1.8

1.7

1357.9

1227.4

nmol/l

0.41

338

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1.18

0.13

1.1

1.3

—

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

167

0.89

0.11

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

1.09

0.09

1.0

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1.09

0.09

2.5

2.6

1.2

1.5

mg/l

—

(4035726)

216

0.92

0.09

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

1.07

0.08

1.0

1.1

—

56.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.05

0.08

1.9

2.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1.03

0.08

1.0

1.9

98.6

97.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.03

0.07

1.3

2.0

2.9

3.2

g/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.84

0.07

2.0

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.06

0.07

1.4

2.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

436

1.04

0.05

1.2

1.3

1.1

12.6

u/ml

3.94

169

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

461

0.97

0.03

1.3

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

108

0.92

0.03

2.3

3.6

48.3

48.6

—

108

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

247

0.97

0.01

1.4

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

129

1.01

0.00

1.2

1.5

—

(21494755) Public health laboratory ask at order entry panel

169

1.01

0.00

1.5

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

275

1.02

0.00

2.2

3.8

29.3

6.1

ug/l

0.66

230

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

877

1.01

0.00

4.0

3.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

205

0.97

0.00

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

0.00

0.0

1.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

0.0

6.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.1

—

(3035880) pH of Pleural fluid

0.00

0.0

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

133.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

4.2

—

215.7

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.0

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.00

0.0

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.0

1.8

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.0

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

109.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.91

0.00

1.2

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

(3003129) Base excess in Capillary blood by calculation

0.00

0.0

1.0

—

4.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.0

7.2

—

(4034850)

0.99

0.00

13.3

9.7

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.4

—

(3008898) HLA-B27 [Presence]

1.00

0.00

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

19.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

52.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

3.4

—

139.2

—

(44806420)

0.00

0.0

2.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

2.5

—

108.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.92

0.00

3.7

2.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.00

0.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.3

—

(3012565) Volume of 24 hour Urine

0.00

0.0

3.3

—

1975.0

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.0

1.5

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.00

0.0

1.0

—

90.8

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

109.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.89

0.00

3.7

4.3

4.0

3.9

mmol/l

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

10.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.0

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_CUTLAXSEN and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_CUTLAXSEN	0.901 [0.73, 1.12]	0.345
Birth year	0.992 [0.98, 1.0]	0.089

During the follow-up period (1.1.1998 — 31.12.2019), 91 out of 879 females with L12_CUTLAXSEN died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_CUTLAXSEN.

N-year risk	Females	Males
1	0.068%	No data
5	0.471%	No data
10	1.246%	No data
15	2.254%	No data
20	3.936%	No data

Relationships between endpoints

↥

Index endpoint: L12_CUTLAXSEN – Cutis laxa senilis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cutis laxa senilis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints